Suzhou Kintor Pharmaceuticals

About:

Kintor is a pharmaceutical research company.

Website: http://www.kintor.com.cn/

Top Investors: Highlight Capital, Oriza Holdings, Huajin Capital, Green Pine Capital Partners, CCB International

Description:

Kintor founded in Suzhou in 2009, focusing on prostate cancer, breast cancer and liver cancer which account for more than 50% of the global cancer population and lack of effective treatment method. They have a product pipeline built on proprietary R&D and licensing arrangement, aiming to provide the best treatment plans for huge unmet patient needs. They focus on developing a full R&D and commercialization platform for “best-in-class” and “first-in-class” novel drugs.

Total Funding Amount:

$99M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Suzhou, Jiangsu, China

Founded Date:

2009-01-01

Contact Email:

xdxu(AT)kintor.com.cn

Founders:

Chuangxin Guo, Youzhi Tong

Number of Employees:

251-500

Last Funding Date:

2019-10-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai